Effect of frequency of clinic visits and medication pick-up on antiretroviral treatment outcomes: A systematic literature review and meta-analysis

Journal of the International AIDS Society

Volumn 20, Issue , 2017, Pages

  Mutasa Apollo, Tsitsi ^a,b   Ford, Nathan ^c,d   Wiens, Matthew ^e,f   Socias, Maria Eugenia ^e,f   Negussie, Eyerusalem ^c   Wu, Ping ^e   Popoff, Evan ^e   Park, Jay ^e   Mills, Edward J ^e   Kanters, Steve ^e,f  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b MINISTRY OF HEALTH AND CHILD CARE   (Zimbabwe)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e Department of Health Analytics   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antiretroviral therapy HIV AIDS; Clinical visit frequency; HIV services; Meta analysis; Systematic literature review

Indexed keywords

AMBULATORY CARE; ANTIRETROVIRAL THERAPY; EXTERNAL VALIDITY; HEALTH CARE DELIVERY; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGRAM EVALUATION; REVIEW; SOCIAL SUPPORT; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICATION COMPLIANCE;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AMBULATORY CARE; ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; TREATMENT OUTCOME;

EID: 85025805749     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.20.5.21647     Document Type: Review

References (35)

1. UNAIDS. "15 by 15". A global target achieved. Geneva: UNAIDS; 2015.
2. Kranzer K, Ford N. Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review. Trop Med Int Health. 2011; 16(10): 1297-313.
3. Rosen S, Fox MP, Gill CJ Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. Plos Med. 2007; 4(10): e298.
4. Boender TS, Sigaloff KC, McMahon J.H., et al. Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low- and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis. 2015; 61 (9):1453-61.
5. IeDEA-WHO Collaboration: global analysis of retention in care in initial HIV care and treatment programmes in the IeDEA regions. 2015.
6. Insight Start Study Group, Lundgren JD, Babiker AG, et al. Initiation of antiretroviral therapy in early asymptomatic HIV Infection. N Engl J Med. 2015; 373(9):795-807.
7. Temprano Anrs Study Group, Danel C, Moh R, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015; 373(9):808-22.
8. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. Aids. 2012; 26 (16):2059-67.
9. Rachlis BS, Mills EJ, Cole DC Livelihood security and adherence to antiretroviral therapy in low and middle income settings: a systematic review. Plos One. 2011; 6(5):e18948.
10. Duncombe C, Rosenblum S, Hellmann N., et al. Reframing HIV care: putting people at the centre of antiretroviral delivery. Trop Med Int Health. 2015; 20(4):430-47.
11. Higgins JP, Altman DG, Gotzsche P.C., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. doi: 10.1136/bmj.d5928.
12. National Institute for Health and Care Excellence (NICE). The gudelines manual: appendix C: methodology checklist: cohort studies. 2012 [cited 2015 Jun 12]. Available from: http://publications.nice.org.uk/the-guidelines-manual-appendices-bi-pmg6b/appendix-c-methodology-checklist-randomised-con trolled-trials
13. Blair D, Choudhary M, Morrison C. Effect of clinic visit frequency on HIV clinical care and virologic outcome. Philadelphia (PA): Infectious Diseases Society of America; 2009.
14. Buscher A, Mugavero M, Westfall A.O., Keruly J., Moore R, Drainoni ML, et al The association of clinical follow-up intervals in HIV-infected persons with viral suppression on subsequent viral suppression. AIDS Patient Care STDS. 2013; 27(8):459-66.
15. Castelino S, Miah H, Auyeung V., Vogt F. Determination of the influence of home delivery of HIV therapy on virological outcomes and adherence. Int J STD AIDS. 2015; 26(2):93-7.
16. Kendall MA, Andersen JW van der Horst C. A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207. Contemp Clin Trials. 2006; 27(3):287-94.
17. McGuire M, Pedrono G, Mukhuna B., Huckabee M, Heinzelmann A, Szumilin E., et al. Optimizing patient monitoring after the first year of ART: three years of implementing 6-monthly clinical appointments in rural Malawi. Paper presented at: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention; 17-20 July 2011.
18. Reekie J, Mocroft A, Sambatakou H., Machala L, Chiesi A, van Lunzen J, et al. Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure? AIDS 2008; 22(17):2381-2390.
19. Babigumira JB, Castelnuovo B, Stergachis A., Kiragga A, Shaefer P, Lamorde M., et al. Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in Uganda. PLoS One. 2011; 6(3):e18193.
20. Bemelmans M, Baert S, Goemaere E., Wilkinson L, Vandendyck M, van Cutsem G, et al. Community-supported models of care for people on HIV treatment in sub-Saharan Africa. Trop Med Int Health. 2014; 19(8):968-77.
21. Decroo T, Telfer B, Biot M., Maikere J, Dezembro S, Cumba L.I., et al. Distribution of antiretroviral treatment through self-forming groups of patients in Tete Province, Mozambique. J Acquir Immune Defic Syndr. 2011; 56 (2):e39-44.
22. Grimsrud A, Lesosky M, Kalombo C., Bekker LG, Myer L. Implementation and operational research: community-based adherence clubs for the management of stable antiretroviral therapy patients in Cape Town, South Africa: a cohort study. J Acquir Immune Defic Syndr. 2016; 71(1):e16-23.
23. Grimsrud A, Patten G, Sharp J., Myer L, Wilkinson L, Bekker LG Extending dispensing intervals for stable patients on ART. J Acquir Immune Defic Syndr. 2014; 66(2):e58-60.
24. Grimsrud A, Sharp J, Kalombo C., Bekker LG, Myer L. Implementation of community-based adherence clubs for stable antiretroviral therapy patients in Cape Town, South Africa. J Int AIDS Soc. 2015; 18:19984.
25. Jaffar S, Amuron B, Foster S., Birungi J, Levin J, Namara G et al. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet. 2009; 374(9707):2080-9.
26. Kipp W, Konde-Lule J, Saunders L.D., Alibhai A., Houston S, Rubaale T et al. Antiretroviral treatment for HIV in rural Uganda: two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort. PLoS One. 2012; 7(7): e40902.
27. Kipp W, Konde-Lule J, Saunders L.D., Alibhai A., Houston S, Rubaale T, et al Results of a community-based antiretroviral treatment program for HIV-1 infection in Western Uganda. Curr HIV Res. 2010; 8(2):179-85.
28. Luque-Fernandez M.A., Van Cutsem G, Goemaere E, Hilderbrand K., Schomaker M, Mantangana N, et al Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One. 2013; 8(2):e56088.
29. Muñoz-Moreno J.A., Fumaz CR, Ferrer M.J., Tuldra A., Andreu A, Bonafont X, et al Influence of the frequency in the medication collection on adherence to antiretroviral therapy of HIV+ patients XV. Paper presented at: International AIDS Conference; 18-22 July 2015.
30. Naslund JA, Dionne-Odom J, Junior Destine C, Jogerst KM, Renold Senecharles R, Jean Louis M et al. Adapting and Implementing a Community Program to Improve Retention in Care among Patients with HIV in Southern Haiti: "Group of 6". AIDS Res Treat 2014; 2014:137545.
31. Selke HM, Kimaiyo S, Sidle J.E., Vedanthan R., Tierney WM, Shen C, et al. Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya. J Acquir Immune Defic Syndr. 2010; 55(4):483-90.
32. Wools-Kaloustian K.K., Sidle JE, Selke H.M., Vedanthan R., Kemboi EK, Boit LJ, et al. A model for extending antiretroviral care beyond the rural health centre. J Int AIDS Soc. 2009; 12:22.
33. Decroo T, Koole O, Remartinez D., dos Santos N, Dezembro S, Jofrisse M., et al. Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique. Trop Med Int Health. 2014; 19(5):514-21.
34. World Health Organization. Consolidated guidelines on the use of anti-retroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO; 2013.
35. Sharma DC. Budget cuts threaten AIDS and tuberculosis control in India. Lancet. 2015; 386(9997):942.